Update on biologic safety for patients with psoriasis during pregnancy

Biologic agents have become more common to treat patients with psoriasis, but concerns about their effect on pregnancy and lactation often preclude this treatment during these time periods. During the past decade, we have gained a much better understanding of the course of psoriasis during pregnancy...

Full description

Bibliographic Details
Main Authors: Martina L. Porter, Stephen J. Lockwood, Alexa B. Kimball
Format: Article
Language:English
Published: Elsevier 2017-03-01
Series:International Journal of Women's Dermatology
Online Access:http://www.sciencedirect.com/science/article/pii/S2352647516300375
id doaj-92d6a49769bb4de2b0bb82d589796eb7
record_format Article
spelling doaj-92d6a49769bb4de2b0bb82d589796eb72020-11-25T01:07:49ZengElsevierInternational Journal of Women's Dermatology2352-64752017-03-01312125Update on biologic safety for patients with psoriasis during pregnancyMartina L. Porter0Stephen J. Lockwood1Alexa B. Kimball2Clinical Unit for Research Trials and Outcomes in Skin (CURTIS), Massachusetts General Hospital, Boston, MAClinical Unit for Research Trials and Outcomes in Skin (CURTIS), Massachusetts General Hospital, Boston, MADepartment of Dermatology, Harvard Medical School, MA; Harvard Medical Faculty Physicians, Beth Israel Deaconess Medical Center, Boston, MA; Corresponding author.Biologic agents have become more common to treat patients with psoriasis, but concerns about their effect on pregnancy and lactation often preclude this treatment during these time periods. During the past decade, we have gained a much better understanding of the course of psoriasis during pregnancy and the safety of the use of biologic agents during pregnancy and lactation. Under certain circumstances, biologic agents can be considered appropriate treatment options for patients who are pregnant or lactating. Keywords: psoriasis, pregnancy, lactation, biologic agents, TNF-alpha inhibitorshttp://www.sciencedirect.com/science/article/pii/S2352647516300375
collection DOAJ
language English
format Article
sources DOAJ
author Martina L. Porter
Stephen J. Lockwood
Alexa B. Kimball
spellingShingle Martina L. Porter
Stephen J. Lockwood
Alexa B. Kimball
Update on biologic safety for patients with psoriasis during pregnancy
International Journal of Women's Dermatology
author_facet Martina L. Porter
Stephen J. Lockwood
Alexa B. Kimball
author_sort Martina L. Porter
title Update on biologic safety for patients with psoriasis during pregnancy
title_short Update on biologic safety for patients with psoriasis during pregnancy
title_full Update on biologic safety for patients with psoriasis during pregnancy
title_fullStr Update on biologic safety for patients with psoriasis during pregnancy
title_full_unstemmed Update on biologic safety for patients with psoriasis during pregnancy
title_sort update on biologic safety for patients with psoriasis during pregnancy
publisher Elsevier
series International Journal of Women's Dermatology
issn 2352-6475
publishDate 2017-03-01
description Biologic agents have become more common to treat patients with psoriasis, but concerns about their effect on pregnancy and lactation often preclude this treatment during these time periods. During the past decade, we have gained a much better understanding of the course of psoriasis during pregnancy and the safety of the use of biologic agents during pregnancy and lactation. Under certain circumstances, biologic agents can be considered appropriate treatment options for patients who are pregnant or lactating. Keywords: psoriasis, pregnancy, lactation, biologic agents, TNF-alpha inhibitors
url http://www.sciencedirect.com/science/article/pii/S2352647516300375
work_keys_str_mv AT martinalporter updateonbiologicsafetyforpatientswithpsoriasisduringpregnancy
AT stephenjlockwood updateonbiologicsafetyforpatientswithpsoriasisduringpregnancy
AT alexabkimball updateonbiologicsafetyforpatientswithpsoriasisduringpregnancy
_version_ 1725185035784421376